MAIA Biotechnology (MAIA) Research & Development (2021 - 2026)

MAIA Biotechnology (MAIA) has reported Research & Development for 6 consecutive years, with $5.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 81.29% year-over-year to $5.6 million in Q2 2026; TTM through Jun 2026 was $17.4 million, a 45.7% increase from a year earlier, with the FY2025 full-year figure at $14.5 million, up 45.34% from the prior year.
• Research & Development was $5.6 million for Q2 2026 at MAIA Biotechnology, up from $3.5 million in the prior quarter.
• Over five years, Research & Development peaked at $6.4 million in Q3 2025 and troughed at $1.9 million in Q4 2025.
• A 5-year average of $3.0 million and a median of $2.6 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development soared 229.12% in 2022 and tumbled 36.63% in 2025, its largest moves.
• Over 5 years, Research & Development stood at $2.4 million in 2022, then surged by 55.32% to $3.7 million in 2023, then decreased by 20.13% to $3.0 million in 2024, then slumped by 36.63% to $1.9 million in 2025, then jumped by 199.72% to $5.6 million in 2026.
• The last three Research & Development figures came in at $5.6 million (Q2 2026), $3.5 million (Q1 2026), and $1.9 million (Q4 2025), per Business Quant data.